The US FDA’s latest direct-to-consumer prescription drug advertising research project could lead to the creation of a program to encourage consumers to report deceptive promotions to the agency.
FDA announced the research project, “Consumer and Healthcare Professional Identification of and Responses to Deceptive Prescription Drug Promotion,” in a...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?